Stockreport

ASLAN Pharmaceuticals Names Industry Veteran and Current Board Member Andrew Howden to Additional Role of Chairman

ASLAN Pharmaceuticals Limited - American Depositary Shares  (ASLN) 
US:NASDAQ Investor Relations: ir.aslanpharma.com
PDF SINGAPORE, July 26, 2019 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage oncology and immunology focused biopharma company, today [Read more]